Thursday, October 11, 2018


FDA's Insanitary Conditions Revised Draft Guidance: Required ...


www.fdalawblog.net/.../fdas-insanitary-conditions-revised-draft-guidance-required-re...

19 hours ago - FDA states that it “generally does not intend to take action under Section 501(a)(2)(A) against a physician who is compounding or repackaging a drug product, or who is mixing, diluting or repackaging a biological product, provided that such activities occur in the physician's office where the products are administered ...
Post a Comment